Navigation Links
$7.5M grant to fund research on interaction of drinking and HIV infection
Date:10/20/2010

PROVIDENCE, R.I. [Brown University] Living with HIV is difficult under the best of circumstances, but for people carrying the virus, alcohol consumption can become particularly perilous in intricate ways that are only beginning to be understood. At the Brown Alcohol Research Center on HIV (ARCH) funded by a new $7.5-million, five-year grant from the National Institutes of Health, Brown University scientists will study the health effects of drinking with HIV and provide doctors and patients with the latest guidance their results suggest.

Alcohol can produce many unique complications and risks in the life of an HIV-positive person, said Peter Monti, the Donald G. Millar Distinguished Professor of Alcohol and Addiction Studies at Brown and the director of the ARCH. Both alcohol and the virus can independently weaken the brain and the liver, for example. Researchers suspect that the confluence of health effects becomes even more complicated when alcohol undermines a patient's adherence to antiretroviral medications or inclination to remain abstinent or engage in safe sex.

"We want healthier individuals living with HIV, especially now that they are living longer," Monti said. "We'll hopefully determine whether people have to stop drinking or reduce their drinking."

Alcohol use is generally understood to be more prevalent among at least some major groups of HIV-positive people than in the general population, said Monti, who directs the Center for Alcohol and Addiction Studies at the Warren Alpert Medical School of Brown University.

Starting studies

The ARCH will be organized to conduct research both on the physiological and behavioral aspects of HIV and alcohol, including funding two major and four pilot studies as well as several cores.

In one study, researchers led by Ronald Cohen, professor of psychiatry and human behavior (research) and director of the Department of Neuropsychology at The Miriam Hospital, will study changes in the brain structure, metabolism, and cognitive functioning of heavier and lighter drinkers with HIV over three years.

In another study at Fenway Health in Boston led by Christopher Kahler, professor of community health (research) and scientific director of the ARCH, and Kenneth Mayer, professor of medicine based at The Miriam, Monti will adapt an effective emergency room alcohol intervention he has developed for a clinical trial with chronic heavy drinkers with HIV. The "motivational interview" technique presents facts and feedback about a patient's consumption compared to that of peers and relays information about the health effects of the patient's level of drinking.

"You don't hammer patients over the head with it, but you present them with the information in a nonconfrontational style and ask them what they think about it," Monti said. "You ask them whether they'd be interested in changing and if the answer is yes, you give them some thumbnail sketches about how they might want to go about that."

In another new but separate $4-million grant, Monti will develop and test an emergency room intervention method to curb sexual risk-taking and heavy alcohol consumption.

The ARCH pilot studies will investigate the role of occult hepatitis C in the HIV and alcohol mix, the effects of HIV and drinking during pregnancy on newborns, the brain response that HIV-positive drinkers have to various stimuli depending on their level of use and acute brain response to alcohol, and the effects of drinking and HIV among fishermen and commercial sex workers in Uganda. Additional pilot studies will be jointly funded by the ARCH and Brown's Center for AIDS Research, directed by Charles Carpenter, professor of medicine based at The Miriam.

Another major element of the program, led by Mayer and Suzanne Colby, associate professor of psychiatry and human behavior (research), will be to educate postdoctoral trainees and doctors in the specialty of alcohol and HIV.

Getting the word out

Throughout ARCH's five-year grant period, the center faculty will share results via newsletters and the Internet with colleagues, clinicians, and patients who so far have many more questions than answers. Monti points out that there are well-established clinical communities around AIDS and around alcohol addiction, but very few clinical, research or education efforts that span both health problems.

"Doctors often ask me what they should tell their HIV positive patients who have no other risk factors than being HIV-positive about whether they can safely take a glass or two of wine with dinner," said Monti. "We simply do not know."


'/>"/>

Contact: David Orenstein
david_orenstein@brown.edu
401-863-1862
Brown University
Source:Eurekalert

Related biology news :

1. BU partners in 5-year, $7.5M grant to study animal flight
2. NSF awards $7.5M grant to University of Oklahoma for plant genomics
3. BMC receives National Institutes of Health grant to study intrauterine cocaine and substance reslience
4. OU researchers awarded $3M DOE grant to determine effects of climate change on two ecosystems
5. NSF grant to study national energy policy and technology impacts
6. Columbia engineer part of team to receive $6.2 million DOD grant for blast research
7. Grant to fund pioneering brain-computer interface technology
8. NSF awards grants to study effects of ocean acidification
9. Grant to explore nanotech anti-infective agent for soldiers wounds
10. Rutgers part of team awarded $3.3 million National Institutes of Health grant for prostate cancer research
11. USDA awards grant to GSU professor to study childhood obesity dynamics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)...  Genos, a community for personal genetic discovery ... Laboratory Accreditation from the College of American Pathologists ... that meet stringent requirements around quality, accuracy and ... "Genos is committed to maintaining the highest ... to be receiving CAP accreditation," said Jill ...
(Date:2/10/2017)... Research and Markets has announced the addition ... and Commercial Aspects" to their offering. ... Biomarkers play an ... for selection of treatment as well for monitoring the results. ... in modern medicine. Biochip/microarray technologies and next generation sequencing are ...
(Date:2/8/2017)... 7, 2017 Report Highlights ... The global synthetic-biology market reached ... by 2021, growing at a compound annual growth rate (CAGR) ... of the global markets for synthetic biology. - Analyses of ... and projections of compound annual growth rates (CAGRs) through 2021. ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... Feb. 23, 2017  In Atlanta, it seems everyone has ... culture intertwine to create an expressive and dynamic community unlike ... energy and contribute to it. With their ... Fairies seeks to carry on that tradition with a ... Atlanta salon is the newest of 13 nationwide ...
(Date:2/23/2017)... ROCHESTER, Minn. , Feb. 23, 2017 /PRNewswire/ ... a new product line of oncolytic vaccinia viruses ... Genelux Corporation as part of Genelux,s proprietary, vaccinia ... "We are excited to enter into a partnership ... time, selected oncolytic vaccinia viruses for use in ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... that in a published evaluation of multiple immunoassay-based threat detection technologies by ... Energy Laboratory, PathSensors’ CANARY® biosensor threat detection technology was found to have ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... as insulin, cortisol, CRP, adiponectin, uric acid, and/or other biomarkers or SNPs of ... Assay from Salimetrics’ SalivaLab , the relationship between insulin and other relevant ...
Breaking Biology Technology: